Inovio Pharmaceuticals, Inc.
INO
|
$10.34
3.19%
3.09%
240K
|
Health Technology
(0.0% 1d) (-16.4% 1m) (1161.9% 1y) (0.0% 2d) (3.5% 3d) (1.7% 7d) (-27.7% volume)
Earnings Calendar: 2023-08-09
Market Cap: $ 241,649,574
http://www.inovio.com
Sec Filling | Patents | 194 employees
(US) Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system’s tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
vaccine cancer immunotherapy optical t-cell ceiling
add to watch list Paper trade email alert is off
Press-releases
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Published: 2024-04-15 (Crawled : 23:00) - prnewswire.com
INO | $10.34 3.19% 3.09% 240K
|
Health Technology
|
| O: -23.66%
H: 21.69%
C: 14.84%
million offering
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
Published: 2024-03-26 (Crawled : 23:00) - prnewswire.com
INO | $10.34 3.19% 3.09% 240K
|
Health Technology
|
| O: 0.0%
H: 6.06%
C: 5.25%
therapeutics
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published: 2024-03-06 (Crawled : 21:00) - prnewswire.com
INO | $10.34 3.19% 3.09% 240K
|
Health Technology
|
| O: -2.23%
H: 0.62%
C: -6.42%
CHRS | $2.19 0.46% 0.46% 810K
|
Health Technology
|
| O: 0.45%
H: 1.13%
C: -0.45%
year financial results
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
Published: 2024-02-21 (Crawled : 16:00) - biospace.com/
INO | $10.34 3.19% 3.09% 240K
|
Health Technology
|
| O: 0.24%
H: 2.19%
C: -3.66%
report financial results
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Published: 2024-02-07 (Crawled : 00:00) - biospace.com/
INO | $10.34 3.19% 3.09% 240K
|
Health Technology
|
| O: -0.94%
H: 4.69%
C: 0.76%
conference life sciences
INOVIO Reports Inducement Grant Under Inducement Plan
Published: 2024-02-02 (Crawled : 13:00) - prnewswire.com
INO | $10.34 3.19% 3.09% 240K
|
Health Technology
|
| O: -1.13%
H: 1.14%
C: -4.0%
grant
INOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
INO | $10.34 3.19% 3.09% 240K
|
Health Technology
|
| O: -11.82%
H: 1.64%
C: -4.9%
INOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
Published: 2024-01-22 (Crawled : 14:30) - biospace.com/
INO | $10.34 3.19% 3.09% 240K
|
Health Technology
|
| O: 0.82%
H: 5.87%
C: 1.74%
respiratory treatment key potential
INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)
Published: 2024-01-04 (Crawled : 20:00) - biospace.com/
INO | $10.34 3.19% 3.09% 240K
|
Health Technology
|
| O: 13.33%
H: 3.39%
C: -2.97%
CHRS | $2.19 0.46% 0.46% 810K
|
Health Technology
|
| O: 0.99%
H: 3.44%
C: -4.26%
ino-3112 collaboration
INOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program
Published: 2024-01-03 (Crawled : 18:00) - biospace.com/
INO | $10.34 3.19% 3.09% 240K
|
Health Technology
|
| O: 2.84%
H: 1.72%
C: -10.24%
ino-3107 approval treatment program potential
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
MEGI | $11.975 1.87% 0.04% 140K
|
|
00:30
CTRN P 29000 | $22.25 0.14% 0.13% 100K
|
Retail Trade
|
22:00
CONN | $3.71 1.37% 1.35% 72K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.6897 39.71% 2.3K
|
Utilities
|
18:30
CMTV P 700 | $15.74 17.43% 12K
|
Finance and Insurance
|
18:30
FNB | $13.63 2.17% 0.0% 2.5M
|
Finance
|
17:30
RMCF | $3.57 0.28% 2.8K
|
Consumer Non-Durables
|
20:10